Sarah Glass, PhD is the Chief Development Officer at n-Lorem Foundation. She has over twenty years of experience as a strategic leader in rare diseases across academic, pharmaceutical, and clinical research organizations. Sarah marries her professional experience with her passion as a nano-rare parent advocate to enhance patient centricity and ensure unwavering commitment to quality and regulatory alignment in drug discovery and development at n-Lorem. She is dedicated to forging partnerships that support the industrialization of nano-rare therapeutic development.